Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZQX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,981
Award facts
- Contract value 100% obligated
- $10,980.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,980.90 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on January 13, 2026, with ultimate completion by January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, with demonstrated capability to fulfill diverse medication requirements across multiple therapeutic domains for military treatment facilities and veterans' healthcare systems. This delivery order for Zepbound, a GLP-1 receptor agonist commonly used for weight management, reflects the company's role in supplying specialized pharmaceutical commodities to support Defense Health Agency and other federal healthcare operations. The parent IDC structure with Cencora, Inc. enables efficient procurement flexibility while maintaining competitive pricing through firm fixed-price arrangements across the Defense Logistics Agency's medical supply network.
Quick answers
Who was awarded contract SPE2DR26F4ZQX?
SPE2DR26F4ZQX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F4ZQX worth?
The government has obligated $10,981 on SPE2DR26F4ZQX.
Is contract SPE2DR26F4ZQX an order under another contract?
Yes. SPE2DR26F4ZQX is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZQX competed?
The extent of competition for SPE2DR26F4ZQX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award